Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2008 2
2009 4
2010 1
2011 5
2012 1
2013 1
2014 2
2015 2
2016 2
2017 1
2018 2
2019 4
2020 4
2021 4
2022 8
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial.
Sonoda T, Umeda Y, Demura Y, Tada T, Nakashima K, Anzai M, Yamaguchi M, Shimada A, Ohi M, Honjo C, Waseda Y, Akai M, Ishizuka T. Sonoda T, et al. Among authors: umeda y. Cancer Med. 2023 Jun;12(12):13041-13053. doi: 10.1002/cam4.5978. Epub 2023 Apr 20. Cancer Med. 2023. PMID: 37081729 Free PMC article. Clinical Trial.
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Imai H, Wasamoto S, Tsuda T, Nagai Y, Kishikawa T, Masubuchi K, Osaki T, Miura Y, Umeda Y, Ono A, Minemura H, Yamada Y, Nakagawa J, Kozu Y, Taniguchi H, Ohta H, Kasai T, Kaira K, Kagamu H. Imai H, et al. Among authors: umeda y. Thorac Cancer. 2023 Sep;14(25):2567-2578. doi: 10.1111/1759-7714.15036. Epub 2023 Jul 19. Thorac Cancer. 2023. PMID: 37469246 Free PMC article.
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
Murata Y, Tanzawa S, Misumi T, Yoshioka H, Miyauchi E, Ninomiya K, Takeshita M, Ito K, Okamoto T, Sugawara S, Kawashima Y, Hashimoto K, Mori M, Miyanaga A, Hayashi A, Tanaka H, Honda R, Nojiri M, Sato Y, Hata A, Masuda K, Kozuki T, Kawamura T, Suzuki T, Yamaguchi T, Asada K, Tetsumoto S, Tanaka H, Watanabe S, Umeda Y, Yamaguchi K, Kuyama S, Tsuruno K, Misumi Y, Kuraishi H, Yoshihara K, Nakao A, Kubo A, Yokoyama T, Watanabe K, Seki N. Murata Y, et al. Among authors: umeda y. JTO Clin Res Rep. 2023 Oct 20;4(12):100593. doi: 10.1016/j.jtocrr.2023.100593. eCollection 2023 Dec. JTO Clin Res Rep. 2023. PMID: 38046378 Free PMC article.
Successful treatment with lenvatinib in a patient with thymic carcinoma presenting with cardiac tamponade: a case report and review of literature.
Nakashima K, Azuma T, Ohta R, Fujii Y, Sato M, Igarashi K, Kadowaki M, Umeda Y, Waseda Y, Anzai M, Kobayashi M, Ishizuka T. Nakashima K, et al. Among authors: umeda y. Anticancer Drugs. 2022 Sep 1;33(8):761-764. doi: 10.1097/CAD.0000000000001332. Epub 2022 Aug 10. Anticancer Drugs. 2022. PMID: 35946531 Review.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Nishioka N, Imai H, Endo M, Notsu A, Doshita K, Igawa S, Yokouchi H, Ninomiya T, Tokito T, Soda S, Fujiwara T, Asao T, Nakamichi S, Kawamura T, Inomata M, Nakashima K, Ito K, Goto Y, Umeda Y, Hirai S, Ushio R, Yokoo K, Takeda T, Fukui T, Ishihara M, Osaki T, Kubo S, Fujiwara T, Yamamoto C, Tsuda T, Tamura N, Hosokawa S, Chihara Y, Ikeda S, Furuya N, Nakahara Y, Miura S, Okamoto H. Nishioka N, et al. Among authors: umeda y. Target Oncol. 2024 May;19(3):423-433. doi: 10.1007/s11523-024-01048-x. Epub 2024 Apr 13. Target Oncol. 2024. PMID: 38613731 Free PMC article.
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
Nishihara-Kato F, Imai H, Tsuda T, Wasamoto S, Nagai Y, Kishikawa T, Miura Y, Ono A, Yamada Y, Masubuchi K, Osaki T, Nakagawa J, Umeda Y, Minemura H, Kozu Y, Taniguchi H, Ohta H, Kaira K, Kagamu H. Nishihara-Kato F, et al. Among authors: umeda y. Oncology. 2024;102(1):30-42. doi: 10.1159/000533604. Epub 2023 Aug 18. Oncology. 2024. PMID: 37598676
Osteogenesis Imperfecta Associated with Dendriform Pulmonary Ossification.
Morikawa M, Fukuda Y, Terasaki Y, Itoh H, Demura Y, Sasaki M, Imamura Y, Honjo C, Umeda Y, Anzai M, Ameshima S, Ishizaki T, Ishizuka T. Morikawa M, et al. Among authors: umeda y. Am J Respir Crit Care Med. 2016 Feb 15;193(4):460-1. doi: 10.1164/rccm.201505-0942IM. Am J Respir Crit Care Med. 2016. PMID: 26431159 No abstract available.
Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review.
Kimura S, Umeda Y, Egashira R, Tabata K, Muramoto A, Morita M, Yamaguchi M, Waseda Y, Imamura Y, Yamauchi T, Ishizuka T. Kimura S, et al. Among authors: umeda y. Intern Med. 2024 Apr 15;63(8):1149-1155. doi: 10.2169/internalmedicine.2201-23. Epub 2023 Sep 1. Intern Med. 2024. PMID: 37661452 Free PMC article. Review.
54 results